ENTPD1 and synovial sarcoma: We previously reported that CD39 was overexpressed by both malignant and non‐malignant peripheral blood T‐cells in SS patients, leading to an ATP‐mediated anti‐proliferative effect on non‐malignant T cells that was abolished in the presence of CD39/CD73/adenosine pathway inhibitors.5, 6